CLINICAL FEATURES AND OUTCOME OF END-STAGE RENAL DISEASE PATIENTS ON MAINTENANCE HEMODIALYSIS ADMITTED TO MEDICAL INTENSIVE CARE UNIT
Main Article Content
Keywords
Abstract
Background: The increasing prevalence of end-stage renal disease (ESRD) has resulted in a growing number of maintenance hemodialysis (MHD) patients, particularly among older individuals with conditions such as diabetic nephropathy and microvascular disease. MHD patients face a higher risk of medical complications, which often leads to their admission to the intensive care unit (ICU). However, there is a notable gap in data regarding the outcomes of MHD patients admitted to ICUs. This study addresses this gap by providing insights into the clinical features and outcomes of MHD patients admitted to the medical ICU.
Objective: This study investigates the epidemiology and outcomes of MHD patients admitted to the ICU, explicitly focusing on assessing the predictive accuracy of the Simplified Acute Physiology Score II (SAPS II) in determining mortality.
Methodology: A prospective observational study was conducted at Bahria International Hospital Lahore, involving 189 consecutive MHD patients admitted to the ICU from January 2021 to December 2022. Data collection included recording patient diagnoses, SAPS II variables, organ system failures (OSFs), and additional laboratory parameters. Multivariate logistic regression analysis was utilized to identify significant predictors of survival at ICU discharge.
Results: Among the 189 patients studied, the average age was 61.2 ± 12.8 years, with a male predominance. Diabetic nephropathy emerged as the most prevalent primary renal disease. ICU mortality showed an upward trend with each additional OSF at admission. Univariate analysis revealed significant associations between non-survivor status and higher SAPS II scores, increased OSFs, longer mechanical ventilation duration, and abnormal serum phosphorus levels. Multivariate analysis confirmed OSFs and mechanical ventilation duration as significant predictors of ICU mortality.
Conclusion: This study sheds light on the changing demographic of MHD patients and underscores the importance of OSFs and mechanical ventilation duration as critical determinants of ICU mortality. The limited predictive utility of SAPS II in this cohort highlights the necessity for tailored prognostic indicators for critically ill MHD patients. These findings offer valuable insights for clinicians managing this vulnerable patient population in the intensive care setting.
References
2. Himmelfarb, J., et al., The current and future landscape of dialysis. Nature Reviews Nephrology, 2020. 16(10): p. 573-585.
3. Williams, M.E., End-Stage Kidney Failure in the Diabetic Patient, in Handbook of Dialysis Therapy. 2023, Elsevier. p. 434-451.
4. García-Martínez, P., et al., Perceived stress in relation to quality of life and resilience in patients with advanced chronic kidney disease undergoing hemodialysis. International journal of environmental research and public health, 2021. 18(2): p. 536.
5. Matyas, C., et al., Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications. Nature Reviews Cardiology, 2021. 18(2): p. 117-135.
6. Jalali, A., et al., Investigation of Cardiopulmonary Complications in Patients with Infection and Prevalence of Intubation in ICU with Radiological Point. Pakistan Heart Journal, 2023. 56(2): p. 906-919.
7. Gourd, N.M. and N. Nikitas, Multiple organ dysfunction syndrome. Journal of intensive care medicine, 2020. 35(12): p. 1564-1575.
8. Asim, M., F. Amin, and A. El-Menyar, Multiple organ dysfunction syndrome: Contemporary insights on the clinicopathological spectrum. Qatar medical journal, 2020. 2020(2): p. 22.
9. Ahlstrand, E., et al., Visual scoring of chest CT at hospital admission predicts hospitalization time and intensive care admission in Covid-19. Infectious Diseases, 2021. 53(8): p. 622-632.
10. Goswami, J., et al., Scoring systems and outcome of chronic kidney disease patients admitted in intensive care units. Saudi Journal of Kidney Diseases and Transplantation, 2018. 29(2): p. 310-317.
11. Christensen, B., et al. Hematology laboratory abnormalities in patients with coronavirus disease 2019 (COVID-19). in Seminars in thrombosis and hemostasis. 2020. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
12. Sahay, M., et al., Aetiology, practice patterns and burden of END‐STAGE kidney disease in South Asia and SOUTH‐EAST Asia: A questionnaire‐based survey. Nephrology, 2021. 26(2): p. 142-152.
13. Dalia, T., et al., Trends and Outcomes of Cardiogenic Shock in Patients With End-Stage Renal Disease: Insights From USRDS Database. Circulation: Heart Failure, 2023. 16(8): p. e010462.
14. Ravani, P., et al., Association of age with risk of kidney failure in adults with stage IV chronic kidney disease in Canada. JAMA network open, 2020. 3(9): p. e2017150-e2017150.
15. Neyra, J.A., et al., Impact of acute kidney injury and CKD on adverse outcomes in critically ill septic patients. Kidney International Reports, 2018. 3(6): p. 1344-1353.
16. Husain‐Syed, F., M.H. Rosner, and C. Ronco, Distant organ dysfunction in acute kidney injury. Acta Physiologica, 2020. 228(2): p. e13357.
17. Brogan, M. and M.J. Ross, The impact of chronic kidney disease on outcomes of patients with COVID-19 admitted to the intensive care unit. Nephron, 2022. 146(1): p. 67-71.